[{"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0177-2022", "product_description": "TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 1MG/ML #2 IN SESAME OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "6 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: T1004202021:52 BUD: 10/17/2021; T1005042021:24 BUD: 10/31/2021", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "68639", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide (Continental USA and Puerto Rico).  A portion of the bulk lot was supplied to Pfizer Germany for packaging into blisters for non- USA market.  One of these lots in Germany was placed in stability having acceptable results, therefore are not part of the recall scope.  Only the product distributed within US/PR market (bottles) is in the scope of this recall.", "recall_number": "D-1485-2014", "product_description": "Cardura XL (doxazosin mesylate extended release tablets, 4 mg, 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., New York, NY 10017,  NDC 0049-2710-30", "product_quantity": "22,461 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Product from this lot may not meet specifications for a product degradant.", "recall_initiation_date": "20140619", "center_classification_date": "20140728", "termination_date": "20150603", "report_date": "20140806", "code_info": "Lot # V130822; Exp 01/15", "more_code_info": ""}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84147", "recalling_firm": "Novitium Pharma LLC", "address_1": "70 Lake Dr", "address_2": "N/A", "postal_code": "08520-5321", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0313-2020", "product_description": "Novitium Pharma Ranitidine Capsules 300 mg 100 capsules Rx Only Manufactured by: Novitium Pharma LLC 70 Lake Drive, East Windsor, New Jersey 08520  NDC 70954-002-40", "product_quantity": "6660 bottles", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191025", "center_classification_date": "20191110", "termination_date": "20210317", "report_date": "20191120", "code_info": "all lots within expiry."}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73925", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0071-2017", "product_description": "methadone HCl, 2.5 mg per 0.5 mL, in 0.9% Sodium Chloride, 0.5 mL Total Volume in a syringe, For IV Use Only, Rx only, PharMEDium, Product code 2T6134.", "product_quantity": "200 syringes", "reason_for_recall": "Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.", "recall_initiation_date": "20150717", "center_classification_date": "20161012", "termination_date": "20170623", "report_date": "20161019", "code_info": "Lot Numbers: 15149041M, 151720043M, 15100060M, 15127064M, Exp between 07/15/15-10/12/15"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091664"], "brand_name": ["METFORMIN HYDROCHLORIDE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-338", "68180-339"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["1807888", "1807915"], "spl_id": ["14bf5106-3b8c-4375-8466-c158c8f8f614"], "spl_set_id": ["1200ea71-8a9e-4e49-bb77-7d9fe0d84ae7"], "package_ndc": ["68180-338-01", "68180-338-02", "68180-338-03", "68180-339-09", "68180-339-01", "68180-339-02"], "is_original_packager": [true], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "85998", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-1383-2020", "product_description": "Metformin Hydrochloride Extended-Release Tablets USP 1000 mg, 90 count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Manufactured by: Lupin Limited, Goa INDIA NDC 68180-339-09", "product_quantity": "95,886 bottles", "reason_for_recall": "CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level", "recall_initiation_date": "20200707", "center_classification_date": "20200714", "termination_date": "20211223", "report_date": "20200722", "code_info": "Batch #   G807093 Jul-20  G807147 Jul-20  G807208 Jul-20  G807479 Jul-20  G807480 Jul-20  G807830 Jul-20  G807092 Jul-20  G809471 Jul-20  G808155 Aug-20  G808074 Aug-20  G808115 Aug-20  G900231 Nov-20  G900232 Nov-20  G903277 Mar-21  G903278 Mar-21  G903279 Mar-21  G903280 Mar-21  G903281 Mar-21  G903818 Apr-21  G904048 Apr-21  G904164 Apr-21  G906548 Jul-21  G907239 Aug-21  G907255 Aug-21  G907256 Aug-21  G907263 Aug-21  G001802 Jan-22  G001804 Jan-22  G001803 Jan-22  G001805 Jan-22  G001806 Jan-22  G001807 Jan-22  G001808 Jan-22  G808154 Aug-20  G900227 Nov-20  G900228 Nov-20  G900229 Nov-20  G900230 Nov-20  G906549 Jul-21  G906550 Jul-21  G906547 Jul-21  G907279 Aug-21  G907364 Aug-21  G001809 Jan-22  G001801 Jan-22  G002563 Feb-22  G002564 Feb-22"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74057", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1360-2016", "product_description": "0.03% Bupivacaine HCl (Preservative Free) in  Sodium Chloride 0.9%, 250 mL Medical Cassette Reservoir, Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-931-11", "product_quantity": "177 Medical Cassettes", "reason_for_recall": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.", "recall_initiation_date": "20160505", "center_classification_date": "20160716", "termination_date": "20180306", "report_date": "20160727", "code_info": "Lot # 160410097M; Exp. 05/16   Lot # 160420107M; Exp. 05/16   Lot # 160460117M; Exp. 05/16   Lot # 160530133M; Exp. 05/16  Lot # 160540206M; Exp. 05/16   Lot # 160570008M; Exp. 05/16    Lot # 160670132M; Exp. 06/16    Lot # 160700001C; Exp. 06/16  Lot # 160770020C; Exp. 06/16  Lot # 160900103C; Exp. 06/16", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "65 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  02252015@51, 5/20/2015; 04222015@22, 7/21/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Fentanyl 7,000 mcg/ml + Bupivacaine 6 mg/ml + Clonidine 40 mcg/ml Intrathecal Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1486-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "66169", "recalling_firm": "Watson Laboratories Inc", "address_1": "132 Business Center Dr", "address_2": "N/A", "postal_code": "92880-1724", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-1061-2013", "product_description": "Hydrocodone Bitartrate and Acetaminophen Tablets, 7.5 mg/650 mg Tablets, 500 Count Bottle, Manufactured by: Watson Laboratories, Inc, Cocona, CA 92880, NDC 0591-2611-05.", "product_quantity": "875 bottles", "reason_for_recall": "Defective Container:  Defective bottles may not have tamper evident seals properly seated, and therefore it may be difficult to determine if the product had been opened or tampered with.", "recall_initiation_date": "20130830", "center_classification_date": "20130917", "termination_date": "20140725", "report_date": "20130925", "code_info": "Lot 706224A and 706225A, Exp. 04/15.", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M014"], "brand_name": ["DEBROX"], "generic_name": ["CARBAMIDE PEROXIDE"], "manufacturer_name": ["Medtech Products Inc."], "product_ndc": ["63029-321"], "product_type": ["HUMAN OTC DRUG"], "route": ["AURICULAR (OTIC)"], "substance_name": ["CARBAMIDE PEROXIDE"], "rxcui": ["702050", "827654"], "spl_id": ["69ef758d-a912-4696-8f5e-ac6cd1aa63dc"], "spl_set_id": ["43649ba3-75e0-4dcf-9172-23767dbaeda6"], "package_ndc": ["63029-321-01", "63029-321-02", "0420371047"], "is_original_packager": [true], "unii": ["31PZ2VAU81"]}, "product_type": "Drugs", "event_id": "90553", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1318-2022", "product_description": "Debrox, Carbamide Peroxide, Earwax Removal Aid, 0.5 FL OZ (15 mL) bottle per box), MedTech Products Inc., NDC 63029-321-01.", "product_quantity": "131 boxes", "reason_for_recall": "CGMP Deviations: products were stored outside the drug label specifications.", "recall_initiation_date": "20220629", "center_classification_date": "20220805", "termination_date": "20240213", "report_date": "20220817", "code_info": "Part# 04203710478", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-921-2015", "product_description": "Terbinafine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "12600 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-706-2015", "product_description": "Histamine Phosphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "5 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1684-2019", "product_description": "MITOMYCIN 0.04% (PF) OPH SOLN, 1ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0917-01", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1703-2019", "product_description": "RXQ CAIN (PHENYLEP 1.5%/ LIDO 1% OPHTH SOL (PF), 1 ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0918-01", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Research Triangle Park", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "69959", "recalling_firm": "Eisai Inc", "address_1": "900 Davis Drive", "address_2": "N/A", "postal_code": "27709", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0302-2015", "product_description": "BELVIQ\u00bf (Lorcaserin HCl) Tablets, 10 mg, 60-count bottle, Rx only, Manufactured by: Arena Pharmaceuticals, GmbH, Zofingen, Switzerland, Distributed by: Elsai Inc., Woodcliff, NJ 07677 NDC 62856-52960.", "product_quantity": "121,680 bottles", "reason_for_recall": "Labeling:Missing Label: Bottles may not have a product label, or have a label with missing or illegible lot number and/or expiry date.", "recall_initiation_date": "20141205", "center_classification_date": "20141216", "termination_date": "20150521", "report_date": "20141224", "code_info": "Lot #13297008, Exp. 11/15;13307008, Exp. 11/15;13367008, Exp.12/15."}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88384", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0345-2022", "product_description": "Perrigo Fexofenadine Hydrochloride tablets, 24HR, 180mg Antihistamine,  100 count bottle, Made in the Czech Republic,  Distributed by Perrigo Allergan, MI 49010 NDC 45802-571-78 UPC 3 45802 571 78 6", "product_quantity": "89,664 containers", "reason_for_recall": "Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.", "recall_initiation_date": "20210727", "center_classification_date": "20220105", "termination_date": "20221108", "report_date": "20220112", "code_info": "Lot 0FR0563, Exp 02/28/22; 0GR0530, Exp 03/31/22; 0KR0434, 0KR0435, 0LR0366,   0LR0367, 0LR0368, Exp 06/30/22."}, {"status": "Ongoing", "city": "High Ridge", "state": "MO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "94366", "recalling_firm": "Integrity Products", "address_1": "5613 Park Road Suite 2", "address_2": "N/A", "postal_code": "63049", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0586-2024", "product_description": "To the Moon Capsules, Horny Goat Weed, 1000 mg, packaged in a box containing a 10-count blister card,  Distributed By: Integrity Products, 1710 Fenpark Dr., Fenton, MO 63026", "product_quantity": "2500 boxes", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Products contain undeclared sildenafil.", "recall_initiation_date": "20240201", "center_classification_date": "20240703", "report_date": "20240710", "code_info": "Lot HGW221116 (Batch 022123-1), Exp 5/31/2025"}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0828-2022", "product_description": "NAD+ Nicotinamide Adenine Dinucleotide Lyophilized powder for reconstitution, Multi-Dose 500 mg Per Vial, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155, Orlando, FL 32835.  NDC 73198-0083-00", "product_quantity": "", "reason_for_recall": "Failed Reconstitution time", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lot: F41116 BUD: 6/16/2022,", "more_code_info": ""}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-997-2013", "product_description": "SERMORELIN ACETATE 10 MG INJECTABLE, all presentations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "03182013@6, 03282013@26,01142013@2, 01182013@2, 01172013@15, 02192013@3, 03062013@8, 04102013@3, 04262013@11, 05142013@35, 05212013@20, 5212013@17, 05242013@6, 06082013@3, 06072013@10, 06182013@27, 06292013@1, 07132013@2, 07232013@3, 03182013@14", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70118", "recalling_firm": "Walgreens Infusion Services", "address_1": "9030 Kirby Dr", "address_2": "N/A", "postal_code": "77054-2504", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas, Florida, Virginia, Georgia, Louisiana, Mississippi", "recall_number": "D-0372-2015", "product_description": "Diphenhydramine 50 mg/ml vials", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20141226", "center_classification_date": "20150116", "termination_date": "20150724", "report_date": "20150128", "code_info": "All products within expiry."}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-910-2015", "product_description": "Tacrolimus Monohydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "647 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Ongoing", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA008845"], "brand_name": ["QUELICIN"], "generic_name": ["SUCCINYLCHOLINE CHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-6629", "0409-6970"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["SUCCINYLCHOLINE CHLORIDE"], "rxcui": ["1594585", "1594587", "1594589", "1594593"], "spl_id": ["85a1ebc8-a6d3-4c1c-8ea1-a1d159f08dd7"], "spl_set_id": ["fb08161e-7711-406d-e7b3-ea4515c07983"], "package_ndc": ["0409-6629-12", "0409-6629-02", "0409-6970-10"], "is_original_packager": [true], "unii": ["I9L0DDD30I"]}, "product_type": "Drugs", "event_id": "73647", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0836-2016", "product_description": "Quelicin (Succinylcholine Chloride) Injection, USP 200 mg. (20 mg/mL), 10 mL Multiple-dose vial, packaged in 25 Unit vials per carton, Rx only, HOSPIRA, INC., LAKE FOREST, IL 60045 USA,  NDC 0409-6629-02", "product_quantity": "103,600 vials", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for the lot number and/or expiration date to be faded or missing from the primary label on the glass vial.", "recall_initiation_date": "20160315", "center_classification_date": "20160504", "report_date": "20160511", "code_info": "Lot 52-045-EV, Exp 07/1/2016", "more_code_info": ""}, {"country": "United States", "city": "Little Rock", "address_1": "1527 S Bowman Rd Ste D", "reason_for_recall": "Lack of Assurance of Sterility: Sterility of product is not assured.", "address_2": "", "product_quantity": "15 Bags", "code_info": "Compounded on 05/28/15, Discard After: 06/11/15", "center_classification_date": "20150701", "distribution_pattern": "United States including: Arkansas", "state": "AR", "product_description": "Ceftazidime 2 gm / NS 50mL, Qty: 15 50 mL Bags, Rx Only.  Compounded by: United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200.", "report_date": "20150708", "classification": "Class II", "openfda": {}, "recalling_firm": "Lincare, Inc.", "recall_number": "D-1201-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71415", "termination_date": "20170216", "more_code_info": "", "recall_initiation_date": "20150528", "postal_code": "72211-4200", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "44 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  03092015@27, 5/20/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Fentanyl 100 mcg/ml +Clonidine 400 mcg/ml Intrathecal Solution, Sterile-Preservative Free,The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1481-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Baudette", "state": "MN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA205401"], "brand_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "manufacturer_name": ["ANI Pharmaceuticals, Inc."], "product_ndc": ["43975-277", "43975-278", "43975-279", "43975-280", "43975-282", "43975-281"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMPHETAMINE DL-ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE"], "rxcui": ["861221", "861223", "861225", "861227", "861232", "861237"], "spl_id": ["d0db10e9-cc85-492d-9f29-663948539b07"], "spl_set_id": ["6438480f-1147-42b6-826d-4e1e1f8ff007"], "package_ndc": ["43975-277-10", "43975-278-10", "43975-279-10", "43975-280-10", "43975-282-10", "43975-281-10"], "is_original_packager": [true], "upc": ["0343975282102", "0343975281105", "0343975278105", "0343975280108", "0343975277108", "0343975279102"], "unii": ["O1ZPV620O4", "G83415V073", "JJ768O327N", "6DPV8NK46S"]}, "product_type": "Drugs", "event_id": "86584", "recalling_firm": "ANI Pharmaceuticals, Inc.", "address_1": "455 Idc Rd Sw", "address_2": "N/A", "postal_code": "56623-2467", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0044-2021", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 10 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-278-10", "product_quantity": "13536 bottles", "reason_for_recall": "Labeling: Incorrect expiration date.  Product dated with 24-month expiration date instead of 18-months.", "recall_initiation_date": "20201009", "center_classification_date": "20201021", "termination_date": "20220119", "report_date": "20201028", "code_info": "Lot: 19S10 Exp. Sept. 2021, 19S11 Exp. Oct. 2021"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0549-2017", "product_description": "LACTIC ACID SOLUTION in all strengths including 20%, 30%, and 60%, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Shelton", "state": "CT", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "90638", "recalling_firm": "Edgewell Personal Care Brands, LLC", "address_1": "6 Research Dr", "address_2": "", "postal_code": "06484-6228", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0212-2024", "product_description": "Banana Boat hair & scalp defense, Clear Sunscreen Spray SPF 30, Avobenzone 2.0%, Homosalate 6.0%, Octocrylene 6.0%, packaged in Net Wt 6 oz. aluminum spray can, Distributed by: Edgewell Personal Care Brands, LLC, Shelton, CT 06484, UPC 0 79656 04041 8", "product_quantity": "139,680  aluminum spray cans", "reason_for_recall": "Chemical contamination: presence of benzene", "recall_initiation_date": "20220729", "center_classification_date": "20231229", "termination_date": "20240209", "report_date": "20220921", "code_info": "Lot #: 20016AF, Exp. date December 30, 2022; 20084BF, Exp. date February 28, 2023; 21139AF, Exp. date April 30, 2024; 20301CF, Exp. date September 30, 2023", "more_code_info": ""}, {"status": "Terminated", "city": "Cedar Rapids", "state": "IA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "90560", "recalling_firm": "Eco Lips, Inc", "address_1": "6000 Huntington Ct Ne", "address_2": "", "postal_code": "52402-1268", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA", "recall_number": "D-1299-2022", "product_description": "Juice Beauty, The Organic Solution, SPF 8, Naturally Clear Lip Moisturizer, Hydratant pour les Levres, NET WT 0.15 oz (4.25 g) per tube,  Active Ingredient: Zinc oxide 4%, Manufactured for Juice Beauty, Inc., 709 Fifth Ave., San Rafael, California 94901-3566", "product_quantity": "35,313 tubes", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20220629", "center_classification_date": "20220727", "termination_date": "20240807", "report_date": "20220803", "code_info": "Lot #: 90122-21015, Exp: 01/24; Lot#: 90122-20356, Exp: 12/23", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "13 ml", "code_info": "All lots distributed between November 2014 and May 2015;  04172015@10/14/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Testosterone Cypionate 200 mg/ml Anastrazole 0.25 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1643-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Overland Park", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69674", "recalling_firm": "Perry Drug Inc.", "address_1": "12200 W 106th St Ste 140", "address_2": "N/A", "postal_code": "66215-2305", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Kansas and Missouri", "recall_number": "D-0259-2015", "product_description": "Testosterone CYP-250/PROP-20 mg, 10 Ml Syringe, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS --- NDC 88888-0326-44", "product_quantity": "1 vial", "reason_for_recall": "Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141107", "center_classification_date": "20141124", "termination_date": "20151103", "report_date": "20141203", "code_info": "141006HH, 11/6/14", "more_code_info": ""}, {"status": "Ongoing", "city": "Dover Plains", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96001", "recalling_firm": "GNMart LLC", "address_1": "7 Sawmill Ln", "address_2": "", "postal_code": "12522-6086", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0170-2025", "product_description": "FORCE FOREVER 400mg Tablets, Huesos y articulaciones sin dolor, SUPLEMENTO ALIMENTICIO, 60-count bottles", "product_quantity": "374 bottles", "reason_for_recall": "Marketed without an approved NDA/ANDA. FDA analysis found the product to be tainted with Diclofenac and Dexamethasone.", "recall_initiation_date": "20241212", "center_classification_date": "20250102", "report_date": "20250108", "code_info": "All lots, Exp. Date: 03/27/2030", "more_code_info": ""}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87266", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0339-2021", "product_description": "Betamethasone Dipropionate Ointment USP, 0.05% (Augmented), packaged in 50 grams tubes, Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 08310, NDC 52565-019-51", "product_quantity": "79,416 tubes", "reason_for_recall": "Failed Impurities/ Degradation Specifications -  OOS for know impurity Betamethasone 17- propionate.", "recall_initiation_date": "20210202", "center_classification_date": "20210423", "termination_date": "20240815", "report_date": "20210505", "code_info": "Lot #: 14297, Exp 9/2021; 15757, Exp 6/2022; 15840, Exp 7/2022; 15970, Exp 9/2022; 15993, Exp 9/2022", "more_code_info": ""}, {"status": "Ongoing", "city": "Fort Mill", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95587", "recalling_firm": "Trinity Gold Nutrition", "address_1": "201 Tom Hall St", "address_2": "STE 2107", "postal_code": "29715-2313", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States; additionally Canada, England, and Australia.", "recall_number": "D-0042-2025", "product_description": "Trinity Gold Nutrition, 60 Capsule, 30 day Supply, Distributed by Trinity Gold Nutrition 201 Tom Hall St. Ste. 2107, Fortmill, SC 29716, USA, Ph: 704-629-8203, www.trinitygold.com, Made in India, UPC 802992001009", "product_quantity": "150", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac and phenylbutazone.", "recall_initiation_date": "20241106", "center_classification_date": "20241112", "report_date": "20241120", "code_info": "Lot #: IN-030, Exp. Date: NOV 2027"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-190-2014", "product_description": "MALE HCG Pk, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "102 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Ongoing", "city": "Mumbai", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA202862"], "brand_name": ["OLANZAPINE"], "generic_name": ["OLANZAPINE"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "product_ndc": ["33342-067", "33342-068", "33342-069", "33342-070", "33342-071", "33342-072"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OLANZAPINE"], "rxcui": ["200034", "283639", "312077", "312078", "312079", "314154"], "spl_id": ["3cb20bd0-3dd5-4742-b2d6-bfbeb8878d31"], "spl_set_id": ["8e095987-bdea-42f2-9550-c7155cf07d30"], "package_ndc": ["33342-067-07", "33342-067-44", "33342-067-12", "33342-067-11", "33342-068-07", "33342-068-44", "33342-068-12", "33342-068-11", "33342-069-07", "33342-069-44", "33342-069-12", "33342-069-11", "33342-070-07", "33342-070-15", "33342-070-12", "33342-070-44", "33342-070-11", "33342-071-07", "33342-071-15", "33342-071-12", "33342-071-44", "33342-071-11", "33342-072-07", "33342-072-15", "33342-072-12", "33342-072-44", "33342-072-11"], "is_original_packager": [true], "upc": ["0333342067074", "0333342070074", "0333342069078", "0333342072078", "0333342071071", "0333342068071"], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["N7U69T4SZR"]}, "product_type": "Drugs", "event_id": "95838", "recalling_firm": "Macleods Pharmaceuticals Ltd", "address_1": "304 Atlanta Arcade", "address_2": "Church Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0154-2025", "product_description": "Olanzapine Tablets, USP 2.5 mg, 30-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured for: Macleods Pharma USA Inc. Princeton, NJ,08540: Manufactured by: Macleods Pharmaceuticals, Ltd. Baddi Himachal Pradesh, INDIA, NDC 33342-067-07.", "product_quantity": "15,744 30-count bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20241125", "center_classification_date": "20241219", "report_date": "20241225", "code_info": "Lot# BOB12318A Exp 07/31/2027", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1010-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (trophamine) 4%/Dextrose 10%, total volume = 250mL, IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0408-1", "product_quantity": "192 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-251201, Exp. 7/10/2023; 36-254907, Exp. 7/22/2023; 36-256030, Exp. 7/28/2023."}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0577-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Blood & Kidney Detox, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955506126, NDC 57955-5061-2", "product_quantity": "975 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 010517C Exp. 01/20; 050216D Exp. 05/19"}, {"status": "Terminated", "city": "New Delhi", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95595", "recalling_firm": "Unexo Life Sciences Private Limited", "address_1": "B16, Sector 4, Bawana Industrial Area", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0071-2025", "product_description": "CHEEKY BONSAI PAIN RELIEF PATCHES, Menthol 10%, 4 patches per box, Distributed by Cheeky Bonsai, San Francisco, CA UPC 8 60006 57564 9", "product_quantity": "17,928 patches", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20241024", "center_classification_date": "20241122", "termination_date": "20250916", "report_date": "20241204", "code_info": "UPC 8 60006 57564 9", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0665-2020", "product_description": "BAC 15MCG/HYDROM 15MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12112019@23 Exp. 12/20/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Gilsum", "state": "NH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66342", "recalling_firm": "W.S. Badger Company Inc.", "address_1": "625 Route 10", "address_2": "N/A", "postal_code": "03448", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Canada, Greece, Singapore, Thailand, Norway, American Samoa.", "recall_number": "D-324-2014", "product_description": "Badger Baby Broad Spectrum SPF 30 Zinc Oxide Sunscreen Lotion Chamomile & Calendula, 4fFl.oz Tube, UPC code: 634084490091 (US)  UPC Code: 634084490114 (Canada)", "product_quantity": "36,272 Tubes", "reason_for_recall": "Microbial Contamination of Non-Sterile Products; Selected lots of Badger Baby and Kids Sunscreen Lotion were recalled due to microbial contamination.", "recall_initiation_date": "20130924", "center_classification_date": "20131205", "termination_date": "20140403", "report_date": "20131211", "code_info": "Lot number 3024A EXP 01/15; 3057A EXP 02/15; 3063A EXP 03/15; 3063B EXP 03/15; 3132A; 3133A EXP 05/15."}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1678-2019", "product_description": "METHYLCOBALAMIN 1 MG/ML (MDV) INJECTABLE SOLUTION, 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0915-10", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0532-2017", "product_description": "BL 20%/4% CREAM, BLT 20%/6%/4% CREAM, BLT 20%/6%/6%, BLT 20% 8% 4% CREAM, BLT 20% 8% 4% OINTMENT, BLT 20% 8% 6% CREAM, BLT 20%/ 8% /8% OINTMENT, BLT 20%/ 8% /8% CREAM, BLT 20%/ 7%/ 7% CREAM,  BLT 20%/ 10%/ 4% CREAM, BLT 20%/ 10%/ 10% CREAM, BLT 20%/ 20%/ 10% OINTMENT,BLT 7%/ 10%/ 7% CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "25 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  05062015@48, 7/5/2015; 03232015@78, 5/22/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "HCG 1,000 IU/ml + Hydroxocobalamin 1,000 mcg/ml Injection, Multi-Dose Vial, Sterile, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1504-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0910-2019", "product_description": "Safecare+ Northeast Regional Allergies Non-Drowsy Homeopathic Taste-Free, Oral Spray, 1 fl oz (29.6 mL), UPC 357955832515, NDC 57955-8325-1", "product_quantity": "0", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 070815H Exp. 07/18"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0731-2019", "product_description": "Dr. King's SafeCare Rx SYP Miasm Constitution, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955030324, NDC 57955-0306-2", "product_quantity": "85 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 012517H Exp. 01/20; 081015N Exp. 08/18"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-809-2015", "product_description": "Mupirocin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1220 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0422-2021", "product_description": "BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM 4MG/1MG  30 POUCHES EACH CONTAINING 1 SUBLINGUAL FILM  NDC/UPC 47781-0356-03; RX; FILM", "product_quantity": "249 CARTONS", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "37890"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "70148", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-459-2015", "product_description": "Robert Wood Johnson University (NJ) Neonatal Starter 5% Dextrose, Trophamine 5%, Dextrose 5%, compound vol: 250 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.", "product_quantity": "2 bags", "reason_for_recall": "Non-Sterility: Out of specification results for the sterility test for microbial contamination.", "recall_initiation_date": "20141217", "center_classification_date": "20150408", "termination_date": "20150819", "report_date": "20150415", "code_info": "lot number 37-74634, Made on 15 DEC 2014, EXP 24 DEC 2014, CAPS Rx: 37-74634-0-2-R, Disp ID: 37-1124681"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80790", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States. Bulk product was distributed to Takeda, Deerfield, IL and may have been further distributed.", "recall_number": "D-0102-2019", "product_description": "PIO&METFORMIN 15/1000 mg Tab 1 (Pioglitazone and Metformin XT) tablets, Takeda Brand Name: Actoplus Met XR (Pioglitazone and metformin HCl extended -release) tablets, 15 mg/1000 mg, packaged in a fiber drum, Application Holder Takeda Pharmaceuticals, U.S.A. Inc. One Takeda Parkway, Deerfield, IL 60015", "product_quantity": "N/A", "reason_for_recall": "Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.", "recall_initiation_date": "20180806", "center_classification_date": "20181025", "termination_date": "20200213", "report_date": "20181031", "code_info": "Bulk Lot no 1250668, 15 mg/1000 mg Bulk product No # 1274150, no NDC Codes, bulk exp. date 05/2020 & 10/2020"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0303-2018", "product_description": "Medline Pacemaker Implant Pack, Sterile, Single Use Only. Packaged in Mexico by Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "66 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNJ32856C; Lots 17SB6210; 17FB5359; 17SB6208", "more_code_info": ""}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92058", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0758-2023", "product_description": "Glimepiride Tablets, USP, 2 mg, RX,  Packaged as a ) 100-count bottle, NDC# 68001-178-00; b) 500-count bottle; NDC# 68001-178-03 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA.  For BluePoint Laboratories", "product_quantity": "105,361 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230317", "center_classification_date": "20230519", "termination_date": "20240906", "report_date": "20230531", "code_info": "Batches a)P2003493, EXP 05/31/2023; P2100120,  EXP 11/30/2023; P2100683, EXP 01/31/2024; P2106002, EXP 07/31/2024; R2200148, EXP 12/31/2024; R2201125, EXP 06/30/2025 b) P2003403, EXP 05/31/2023;  b) P2005800, EXP 09/30/2023; P2101156, EXP 01/31/2024; P2105401, EXP 07/31/2024; R2200083, EXP 12/31/2024; R2201004, EXP 07/31/2025"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0582-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Leg Cramp & Spasm Relief, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955543527, NDC 57955-6035-2", "product_quantity": "9405 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 041518J Exp. 04/20; 050516F Exp. 05/19; 101416A Exp. 10/19; 102816D Exp. 10/19; 123115D Exp. 12/18"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA200403"], "brand_name": ["HYDROMORPHONE HYDROCHLORIDE"], "generic_name": ["HYDROMORPHONE HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-1283", "0409-2552", "0409-3356", "0409-2540", "0409-3365", "0409-1312", "0409-1304"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["HYDROMORPHONE HYDROCHLORIDE"], "rxcui": ["897653", "897753", "897756", "897757", "897758", "1433251", "1724276", "1724383", "1724644"], "spl_id": ["58ff0e68-b78f-4ebd-a91b-b53bbdefc544"], "spl_set_id": ["e9c9ef18-7dfc-4322-b2fc-29b934c30f8b"], "package_ndc": ["0409-2552-11", "0409-2552-01", "0409-3356-11", "0409-3356-01", "0409-2540-11", "0409-2540-01", "0409-3365-11", "0409-3365-01", "0409-3365-10", "0409-1283-03", "0409-1283-31", "0409-1283-09", "0409-1283-10", "0409-1283-04", "0409-1283-05", "0409-1312-03", "0409-1312-30", "0409-1312-09", "0409-1312-10", "0409-1304-03", "0409-1304-31"], "is_original_packager": [true], "unii": ["L960UP2KRW"]}, "product_type": "Drugs", "event_id": "62854", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-020-2013", "product_description": "HYDROmorphone HCl Injection, USP, 2 mg/mL, 1 mL fill in a 2.5 mL Carpuject prefilled cartridge unit, packaged in 10-count Carpujects per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1312-30, Barcode (01) 1 030409 131230 9 (carton), (01) 0 030409 131230 2 (cartridge unit).", "product_quantity": "216,880 cartridge units", "reason_for_recall": "Superpotent (Single Ingredient) Drug: The prefilled cartridge unit has been found to be overfilled and contain more than the 1 mL labeled fill volume.", "recall_initiation_date": "20120815", "center_classification_date": "20121024", "termination_date": "20150529", "report_date": "20121031", "code_info": "Lot 12720LL, Exp 12/01/13"}, {"country": "United States", "city": "Little Rock", "address_1": "8821 Knoedl Ct", "reason_for_recall": "Presence of particulate.", "address_2": "", "product_quantity": "421 syringes", "code_info": "Lot: 20141223@20", "center_classification_date": "20150422", "distribution_pattern": "IN, AR, MO, MN", "state": "AR", "product_description": "Droperidol injection, 2.5 mg/mL, 5 mg Total Dose, 2 mL Fill Volume per syringe, packaged in 10-count syringes per heat sealed bag,  RX only; Compounded for Office Use by SCA Pharmaceuticals, Little Rock, AR (877 ) 550-5059 Bar Code 88888-7720-16", "report_date": "20150429", "classification": "Class II", "openfda": {}, "recalling_firm": "SCA Pharmaceuticals", "recall_number": "D-0965-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "70583", "termination_date": "20161209", "more_code_info": "", "recall_initiation_date": "20150224", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1113-2020", "product_description": "Blood Clot Purger, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0208-2021", "product_description": "SUCccinylcholine Chloride 200 mg/10 mL, (20 mg/mL), Rx Only, 10 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004090812", "product_quantity": "3,239 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220023028, BUD 1/19/2021; 1220023124, BUD 1/25/2021; 1220023162, BUD 1/26/2021 & 1220023210, BUD 1/28/2021.", "more_code_info": ""}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "120 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #: 08292013@10", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "NALOXONE HCL* 0.4MG/ML INJECTABLE, all sizes, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-433-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0218-2020", "product_description": "S-ESTRADIOL CYP 5MG/ML MDV INJ IN ETHYL OLEATE, packaged in a) 5ml, b) 10 ml, glass vials, Rx Only, Red Mountain Compounding RX", "product_quantity": "11 5ml and 10ml glass vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #: S05092019DH@08, Exp 8/9/19; S06112019DH@14, Exp 9/11/19; S07222019DH@04, Exp 10/22/19;"}, {"country": "United States", "city": "Berlin", "address_1": "15 Massirio Dr Ste 201", "reason_for_recall": "CGMP Deviations: During manufacturing Solifenacin Succinate Tablets might convert to Solifenacin Tartrate Tablets.", "address_2": "", "product_quantity": "11,250 bottles", "code_info": "Lot #: a) 81244, 81217, Exp. Date 01/2021 and b) 81245, Exp. Date 01/2021", "center_classification_date": "20200323", "distribution_pattern": "Product was distributed nationwide within the United States.", "state": "CT", "product_description": "Solifenacin Succinate Tablets, 5mg, packaged in a) 30-count bottles (NDC 51991-893-33) and b) 90-count bottles (NDC 51991-893-90) Distributed by: Breckenridge Pharmaceutical, Inc. Boca Raton, FL 33487; Manufactured by: Piramal Enterprises Limited Plot No 67-70, Sector -2 Pithampur 454 775, Dist, Dhar Madhya Pradesh, INDIA", "report_date": "20200325", "classification": "Class II", "openfda": {}, "recalling_firm": "Breckenridge Pharmaceutical, Inc", "recall_number": "D-1050-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "85186", "termination_date": "20201019", "more_code_info": "", "recall_initiation_date": "20200124", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0184-2015", "product_description": "COPPER (SULF), 0.4 mg/mL, injectable, 20 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "600 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140919@21, discard date: 11/3/2014"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "4 units", "code_info": "Rx #'s:  0393869    0393871    0356246    0357036", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DOXORUBICIN HCL, LYOPHILIZED 10MG VIAL 2 VIAL; DOXORUBICIN HCL, LYOPHILIZED 50MG VIAL 1 VIAL, 10 VIAL, 5 VIAL (4 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1509-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77856", "recalling_firm": "PharMedium Services, Llc", "address_1": "12620 W Airport Blvd Ste 130", "address_2": "N/A", "postal_code": "77478-6200", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1166-2017", "product_description": "Fentanyl Citrate (Preservative Free) 20 mcg per mL (2,000 mcg per 100 mL) 100 mL total volume in a 100 mL LifeCare Bag in Sodium Chloride 0.9% Rx Only, Compounded by PharMEDium Services, LLC, Cleveland, MS 38732,   NDC 61553-605-52", "product_quantity": "295 bags", "reason_for_recall": "Labeling: Not Elsewhere Classified-  Diluent used to compound product expired prior to the expiration date assigned to the compounded product.", "recall_initiation_date": "20170406", "center_classification_date": "20170915", "termination_date": "20200113", "report_date": "20170927", "code_info": "Lot: 170850021C Exp. 06/25/17", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA076667"], "brand_name": ["FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI"], "generic_name": ["FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI"], "manufacturer_name": ["CVS Pharmacy"], "product_ndc": ["69842-249"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["FEXOFENADINE HYDROCHLORIDE", "PSEUDOEPHEDRINE HYDROCHLORIDE"], "rxcui": ["997406"], "spl_id": ["de0cfc4c-d1e7-4c5e-1d66-89beb495dc27"], "spl_set_id": ["d106f6b3-36df-e926-c298-b030dc79dbe6"], "package_ndc": ["69842-249-20", "69842-249-30"], "original_packager_product_ndc": ["55111-447"], "unii": ["2S068B75ZU", "6V9V2RYJ8N"]}, "product_type": "Drugs", "event_id": "89042", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "N/A", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide.", "recall_number": "D-0273-2022", "product_description": "Allergy Relief D Fexofenadine HCl, 60 mg I Pseudoephedrine HCl, 120 mg, Extended Release Tablets,  30 Extended-Release Tablets USP,  Distributed By CVS Pharmacy Inc., One CVS Drive, Woonsocket, RI 02985, Made in India, NDC 69842-249-30", "product_quantity": "N/A", "reason_for_recall": "Failed dissolution specifications", "recall_initiation_date": "20211112", "center_classification_date": "20211207", "termination_date": "20230623", "report_date": "20211215", "code_info": "Lot #: AC2103329C, Exp 1/2023", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "89 ml total", "code_info": "All lots distributed between November 2014 and May 2015;  04132015@52, 6/12/2015; 04232015@26, 6/22/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "HCG 1,100 IU/ml Injection, Multi-Dose Vial, Sterile, Refrigerate, 30 DAY KIT, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1527-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "944 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  04142015@54, 6/13/2015; 04092015@68, 6/8/2015; 02252015@6, 5/26/2015; 05042015@68, 7/3/2015; 03022015@20, 05/31/2015; 031192015@5, 6/9/2015; 03092015@22, 6/7/2015; 03122015@3, 6/10/2015; 03162015@81, 6/14/2015; 03242015@74, 6/22/2015, 03302015@64, 6/28/2015; 04062015@46, 7/5/2015; 04212015@25, 6/20/2015; 04222015@18, 6/21/2015, 04242015@56, 6/23/2015; 04272015@29, 6/26/2015; 05012015@18, 6/30/2015; 05082015@32, 7/7/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Morphine 50 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1607-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75650", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "N/A", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0457-2017", "product_description": "Nystatin Oral Suspension, USP 100,000 units per mL, a) 2 fl. oz. (60 mL), 24 bottles per case (NDC 66689-008-02), b) 16 fl. oz. (237 mL), 12 bottles per case (NDC 66689-008-16), Rx only, Manufactured by VistaPharm, Largo, FL 33771", "product_quantity": "67,955 bottles", "reason_for_recall": "CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.", "recall_initiation_date": "20170118", "center_classification_date": "20170202", "termination_date": "20210826", "report_date": "20170208", "code_info": "a) Lot No. 422600 (Exp. 10/17), 420000 (Exp. 09/17), 416100 (Exp. 08/17), 417400 (Exp. 09/17)  b) Lot No. 424200 (Exp. 10/17), 415500 (Exp. 03/18)", "more_code_info": ""}, {"status": "Terminated", "city": "Greenville", "state": "SC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "86409", "recalling_firm": "PAI Holdings, LLC. dba Pharmaceutical Associates Inc", "address_1": "1700 Perimeter Rd", "address_2": "N/A", "postal_code": "29605-5252", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0015-2021", "product_description": "Citalopram Oral Solution, USP 20 mg/10 mL, 10 mL unit dose cups, Rx Only, Mfg for: Pharmaceutical Associates, Inc. Greenville, SC 29605 NDC 0121-1696-40", "product_quantity": "13480 cups", "reason_for_recall": "Failed Impurities/Degradation Specifications; high out of specification results obtained at the 9 month stability timepoint", "recall_initiation_date": "20200909", "center_classification_date": "20201005", "termination_date": "20220222", "report_date": "20201014", "code_info": "Lots: C1EE Exp. 04/2021, BD82 Exp. 11/2020, BD83 Exp. 11/2020, C16D Exp. 02/2021, C563 Exp. 11/2021, C574 Exp. 11/2021"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0959-2019", "product_description": "Dr. King's Acute Pain Relief Cooling Topical, 89 mL (topical cream), Manufactured by: King Bio, Inc. 3 Westside Dr. Asheville, NC 28806 Imported by Ambiental Solutions, Inc. Vancouver, BC, V5Y 1E6, DIN-HM 80074489 UPC 357955181439", "product_quantity": "192 tubes", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 020417ZZ Exp. 02/20"}, {"status": "Terminated", "city": "Edison", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68793", "recalling_firm": "Daiichi Sankyo Pharma Development", "address_1": "399 Thornall St", "address_2": "", "postal_code": "08837-2236", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1506-2014", "product_description": "Benicar Tablets (olmesartan medoxomil) 40 mg, 30 and 90 count, Rx Only Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-104-30 and 65597-104-90", "product_quantity": "", "reason_for_recall": "Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.", "recall_initiation_date": "20140712", "center_classification_date": "20140731", "termination_date": "20150316", "report_date": "20140806", "code_info": "30 count - Lot #0002096  Exp - 12/31/2016;   90 count - Lot #0002058  Exp -12/31/2016", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["PAPAVERINE HYDROCHLORIDE"], "generic_name": ["PAPAVERINE HYDROCHLORIDE"], "manufacturer_name": ["Oryza Pharmaceuticals Inc."], "product_ndc": ["72516-024"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PAPAVERINE HYDROCHLORIDE"], "rxcui": ["1789947"], "spl_id": ["2b4bd8c6-2b93-d435-e063-6394a90ae742"], "spl_set_id": ["5ba6e650-a5b5-4381-a62a-b7a6df73e8e6"], "package_ndc": ["72516-024-25", "72516-024-10"], "is_original_packager": [true], "unii": ["23473EC6BQ"]}, "product_type": "Drugs", "event_id": "89803", "recalling_firm": "Vitae Enim Vitae Scientific, Inc.", "address_1": "3030 Bunker Hill St Ste 203", "address_2": "", "postal_code": "92109-5754", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the U.S.A", "recall_number": "D-0742-2022", "product_description": "PAPAVERINE HYDROCHLORIDE Injection, USP, 60 mg/2mL (30 mg/mL), packaged as a) 25 x 2mL Single Use Vials per box (NDC 72516-024-25) and b) 10 x 2mL Single Use Vials per box (NDC 72516-024-10); Manufactured for Oryza Pharmaceuticals, Inc.", "product_quantity": "a) 2,098 boxes; b) 700 boxes", "reason_for_recall": "Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.", "recall_initiation_date": "20220314", "center_classification_date": "20220405", "termination_date": "20240815", "report_date": "20220413", "code_info": "Lot #: a) 20VPHI037, 20VPHI038, 20VPHI039, Exp 12/31/2022; 21VPHI021, 21VPHI022, 21VPHI023, Exp 6/30/2023; 21VPHI047, 21VPHI048, Exp 10/31/2023; b) 21VPHI023, Exp 6/30/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Bronx", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "73018", "recalling_firm": "R Thomas Marketing, LLC", "address_1": "3704 White Plains Rd", "address_2": "N/A", "postal_code": "10467-5710", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide via Internet sales", "recall_number": "D-0886-2016", "product_description": "Real Skill, packaged in 20 small boxes / 4 capsules per box / 80 capsules total, Distributed by: R Thomas Marketing, LLC, Bronx, NY 10467", "product_quantity": "unknown", "reason_for_recall": "Marketed Without An Approved NDA/ANDA", "recall_initiation_date": "20160109", "center_classification_date": "20160526", "termination_date": "20190621", "report_date": "20160601", "code_info": "all lots"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-850-2015", "product_description": "Potassium Chloride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "25000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Portland", "address_1": "2855 Sw Patton Rd", "reason_for_recall": "Incorrect Product Formulation: Vials labeled as Testosterone Cypionate 200 mg/mL in Sesame Oil are being recalled because they contains Estradiol Valerate 20 mg/mL.", "address_2": "Suite A", "product_quantity": "365 vials", "code_info": "Lot # T-1201S14, Exp 5/30/2015", "center_classification_date": "20150528", "distribution_pattern": "Nationwide", "state": "OR", "product_description": "Testosterone Cypionate 200 mg/mL in Sesame oil, 10 mL amber glass vial, Rx Only, Lot# T-1201S14, Compounded by Strohecker's Pharmacy.", "report_date": "20150603", "classification": "Class I", "openfda": {}, "recalling_firm": "Stroheckers Inc Pharmacy", "recall_number": "D-1088-2015", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "71168", "termination_date": "20160201", "more_code_info": "", "recall_initiation_date": "20150412", "postal_code": "97201-1700", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86343", "recalling_firm": "RLC Labs Inc.", "address_1": "1850 E Riverview Dr", "address_2": "N/A", "postal_code": "85034-6703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-1611-2020", "product_description": "WP Thyroid, Westhroid Pure, 1.5 Grain (97.5 mg) Thyroid USP packaged in a) 1,000 Tablets, NDC 64727-5850-2 ; b) 30 Tablets, NDC  64727-5850-4; c) 60 Tablets, NDC 64727-5850-5; d) 90 Tablets, NDC 64727-5850-6; e) 100 Tablets, NDC  64727-5850-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: manufactured under the same conditions as those found to be subpotent.", "recall_initiation_date": "20200825", "center_classification_date": "20200924", "termination_date": "20231108", "report_date": "20200923", "code_info": "All lots with expiry between 10/2020-07/2023"}, {"country": "United States", "city": "Berkeley", "address_1": "2320 Woolsey St", "reason_for_recall": "Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.", "address_2": "", "product_quantity": "5 ml", "code_info": "All lots", "center_classification_date": "20160217", "distribution_pattern": "CA", "state": "CA", "product_description": "papaverine phentolamine, 35 mg/2.5 mg/mL; 5 mL  unit size;   refrigerate,This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705", "report_date": "20160224", "classification": "Class II", "openfda": {}, "recalling_firm": "Abbott's Compounding Pharmacy, Inc.", "recall_number": "D-0691-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73090", "termination_date": "20170406", "more_code_info": "", "recall_initiation_date": "20160115", "postal_code": "94705-1973", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206083"], "brand_name": ["VALSARTAN AND HYDROCHLOROTHIAZIDE"], "generic_name": ["VALSARTAN AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Solco Healthcare US, LLC"], "product_ndc": ["43547-311", "43547-312", "43547-313", "43547-314", "43547-315"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "VALSARTAN"], "rxcui": ["200284", "200285", "349353", "636042", "636045"], "spl_id": ["1b876e29-1212-4e28-8d3c-e2e717a8fe53"], "spl_set_id": ["f8b0a8ab-4549-4553-a127-bf2c0291a4b1"], "package_ndc": ["43547-311-03", "43547-311-09", "43547-311-50", "43547-312-03", "43547-312-09", "43547-312-50", "43547-313-03", "43547-313-09", "43547-313-50", "43547-314-03", "43547-314-09", "43547-314-50", "43547-315-03", "43547-315-09", "43547-315-50"], "is_original_packager": [true], "upc": ["0343547313036", "0343547314033", "0343547315030", "0343547311032", "0343547312039"], "nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "unii": ["0J48LPH2TH", "80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "80525", "recalling_firm": "Prinston Pharmaceutical Inc", "address_1": "2002 Eastpark Blvd", "address_2": "N/A", "postal_code": "08512-3514", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States", "recall_number": "D-0972-2018", "product_description": "Solco Healthcare US Valsartan and Hydrochlorothiazide, USP, 80 MG/12.5 MG Tablets, 90-count bottles, Rx Only, Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd.  Xynqiao, Linhai, Zhejiang 317024, China  Distributed by:  Solco Healthcare US, LLC  Cranbury, NJ 08512 USA   NDC 43547-311-09", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180713", "center_classification_date": "20180720", "report_date": "20180801", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0066-2015", "product_description": "Cefazolin forte 25 mg/mL opthalmic solution packaged in an opaque squeeze bottle eye dropper, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "20 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 06062014@21, Exp 9/4/2014; 06062014@25, Exp 9/4/2014", "more_code_info": ""}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1 vial", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Novarel \"HCG\" 10000U/Vial, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0439-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Venice", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87828", "recalling_firm": "Scentsational Soaps & Candles Inc", "address_1": "730 Commerce Dr", "address_2": "N/A", "postal_code": "34292-1726", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0669-2021", "product_description": "SS Lavender & Herbs Scented Sanitizer, Alcohol Antiseptic 70%, Non-sterile Topical Solution, 3.38 FL. OZ. (100 mL) a) Black and White Collection; b) Photo Real Collection", "product_quantity": "a) 5,112 bottles; b) 4,968 bottles", "reason_for_recall": "Chemical contamination: product found to be contaminated with methanol (wood alcohol), benzene and acetaldehyde.", "recall_initiation_date": "20210427", "center_classification_date": "20210719", "termination_date": "20221202", "report_date": "20210728", "code_info": "Lots #: a) 20253, b) 20252", "more_code_info": ""}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0491-2022", "product_description": "EXTRA STRENGTH UN-ASPIRIN (acetaminophen 500 mg) 2 Caplet packets, Dist. by ZEE Medical Distributors, LLC Mason, OH 45040, NDC 42961-041-03", "product_quantity": "1,694,200 packets", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: AK9599, Exp. Date 05/2022; AK9648, (L) 104, Exp. Date 06/2022"}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1751-2019", "product_description": "AZACITIDINE 125 MG / 5 ML SUB-Q SYRINGE; AZACITIDINE 75 MG (3 ML) SYRINGE, AZACITIDINE 135 MG / 5.4 ML SUB-Q SYRINGE, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0028-2023", "product_description": "AUTOLOGUS TEARS SERUM SOLN FULL STRENGTH, 3 mL droptainers, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "168 droptainers", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 65521, BUD: 10/15/2022; 65545, BUD: 10/15/2022; 65605, BUD: 10/16/2022; 65658, BUD: 10/17/2022; 65733, BUD: 10/21/2022; 65894, BUD: 10/24/2022; 66019, BUD: 10/28/2022; 66120, BUD: 10/30/2022; 66388, BUD: 11/6/2022; 66755, BUD: 11/14/2022; 66870, UD: 11/18/2022; 66928, BUD: 11/19/2022"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74135", "recalling_firm": "Profarma Distributors LLC", "address_1": "4751 Poth Rd", "address_2": "N/A", "postal_code": "43213-1331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1040-2016", "product_description": "tabcin NOCHE; Capsules,12-count box, UPC 501008485033", "product_quantity": "31 boxes ( 372 capsules)", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20160511", "center_classification_date": "20160617", "termination_date": "20170124", "report_date": "20160629", "code_info": "Lot # X223FS; Exp. 11/17"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0947-2023", "product_description": "rocuronium50 mg/5 mL (10 mg/mL), Syringes Rx only, this drug was repackaged by CAPS Inc, 2200 South 43rd Avenue, Pheonix, AZ, NDC 72196-6010-1.", "product_quantity": "77,554 Syringes.", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-238805, 36-238806, 36-238808, 36-238809, 36-238810, 36-238811, Exp. 7/10/2023; 36-239229, 36-239319, 36-239320, 36-239321, 36-239322, Exp. 7/11/2023; 36-239453, 36-239454, 36-239455, Exp. 7/12/2023; 36-239851, 36-239852, Exp. 7/13/2023; 36-240204, Exp. 7/16/2023; 36-240509, 36-240510, 36-240511, Exp. 7/17/2023; 36-241263, 36-241266, Exp. 7/19/2023; 36-241362, 36-241363, 36-241365, Exp. 7/20/2023; 36-241880, 36-241881, 36-241882, Exp. 7/23/2023; 36-242376, 36-242377, Exp. 7/24/2023; 36-242603, 36-242618, Exp. 7/25/2023; 36-242643, 36-242644, 36-242645, Exp. 7/26/2023; 36-243534, 36-243535, Exp. 7/30/2023; 36-243831, Exp. 7/31/2023; 36-244831, 36-244833, 36-244841, 36-244842, 36-244845, 36-244855, Exp. 8/01/2023; 36-245803, Exp. 8/02/2023; 36-246288, 36-246289, 36-246290, 36-246291, 36-246369, Exp. 8/03/2023; 36-246775, 36-246776, 36-246777, 36-246778, 36-246779, Exp. 8/07/2023; 36-248327, Exp. 8/13/2023; 36-249504, 36-249505, Exp. 8/18/2023; 36-249685, 36-249686, 36-249687, Exp. 8/20/2023; 36-249746, 36-249748, 36-249749, 36-249751, 36-249752, 36-249753, Exp. 8/21/2023; 36-250070, 36-250071, Exp. 8/22/2023; 36-250416, 36-250417, 36-250418, 36-250419, 36-250420, 36-250421, Exp. 8/23/2023; 36-251027, 36-251028, Exp. 8/24/2023; 36-251566, 36-251567, 36-251568, Exp. 8/28/2023; 36-251772, 36-251773, 36-251774, 36-251775, Exp. 8/29/2023; 36-252323, Exp. 8/31/2023"}, {"status": "Ongoing", "city": "Aurangabad, Maharashtra State", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA077568"], "brand_name": ["CIPROFLOXACIN"], "generic_name": ["CIPROFLOXACIN"], "manufacturer_name": ["Leading Pharma, LLC"], "product_ndc": ["69315-308"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CIPROFLOXACIN HYDROCHLORIDE"], "rxcui": ["309307"], "spl_id": ["8217ec14-6498-4c35-a5a9-511b451b9459"], "spl_set_id": ["545527e7-05c7-4dbf-ab32-b3fa463d55b0"], "package_ndc": ["69315-308-02", "69315-308-05", "69315-308-10"], "is_original_packager": [true], "upc": ["0369315308028", "0369315308059"], "unii": ["4BA73M5E37"]}, "product_type": "Drugs", "event_id": "95027", "recalling_firm": "FDC Limited", "address_1": "B-8 MIDC Industrial Area", "address_2": "Waluj District", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. A. Nationwide", "recall_number": "D-0623-2024", "product_description": "Ciprofloxacin ophthalmic solution USP, 0.3% as base, package in bottles: a) 10 mL (NDC 69315-308-10), b) 2.5 mL (NDC 69315-308-02), Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India.", "product_quantity": "66,528 bottles", "reason_for_recall": "Defective container: unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.", "recall_initiation_date": "20240723", "center_classification_date": "20240801", "report_date": "20240807", "code_info": "Lot#: a) 084C040, Exp 02/28/2026; b) 084A024, Exp12/31/2025."}, {"status": "Terminated", "city": "Chicago", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA211668"], "brand_name": ["CISATRACURIUM BESYLATE"], "generic_name": ["CISATRACURIUM BESYLATE"], "manufacturer_name": ["Meitheal Pharmaceuticals Inc."], "product_ndc": ["71288-712", "71288-714", "71288-713"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CISATRACURIUM BESYLATE"], "rxcui": ["199211", "199212", "1730194"], "spl_id": ["d3c597b7-517b-4d79-9fdd-fa88f920111a"], "spl_set_id": ["7c8c41b6-d07c-4740-84b7-603289104c59"], "package_ndc": ["71288-712-05", "71288-712-06", "71288-714-10", "71288-714-11", "71288-713-20", "71288-713-21"], "is_original_packager": [true], "unii": ["80YS8O1MBS"]}, "product_type": "Drugs", "event_id": "87224", "recalling_firm": "Meitheal Pharmaceuticals Inc", "address_1": "8700 W Bryn Mawr Ave Ste 600", "address_2": "N/A", "postal_code": "60631-3512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide USA", "recall_number": "D-0286-2021", "product_description": "Cisatracurium Besylate Injection, USP, 10mg per 5mL (2 mg per mL), Single-Dose Vial (NDC 71288-712-05), packaged as 10 x 5 mL Single-Dose Vials per carton (NDC 71288-712-06),  Rx only, Mfd. for Meitheal Pharmaceuticals, Chicago, IL 60631.", "product_quantity": "34,860 vials", "reason_for_recall": "Labeling: Label mix-up: Carton of Cisatracurium Besylate Injection, USP was observed to contain ten vials mislabeled as Phenylephrine Hydrochloride Injection, USP, but confirmed to contain Cisatracurium", "recall_initiation_date": "20210127", "center_classification_date": "20210222", "termination_date": "20231016", "report_date": "20210303", "code_info": "Lot C11507A"}, {"status": "Terminated", "city": "Aurora", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71535", "recalling_firm": "the Compounder", "address_1": "340 Marshall Ave Unit 100", "address_2": "N/A", "postal_code": "60506-5649", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0223-2016", "product_description": "ESTRIOL (E3) W/V (weight/volume) VERSABASE  3MG/ML Transdermal cream, dispensed in 5 mL prefilled, amber syringes, Rx only, The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.", "product_quantity": "6  (5mL) syringes", "reason_for_recall": "Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.", "recall_initiation_date": "20150310", "center_classification_date": "20151110", "termination_date": "20160519", "report_date": "20151118", "code_info": "Lot # 01232015:87@5, Exp 7/22/2015"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "70148", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-464-2015", "product_description": "Lankenau Hospital (PA) TPN Neonatal Starter Bag, Trophamine 2.5%, Dextrose 10%, Additives: heparin PF 62.5 units, Calcium Gluconate 500mg, compound vol: 250 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.", "product_quantity": "6 bags", "reason_for_recall": "Non-Sterility: Out of specification results for the sterility test for microbial contamination.", "recall_initiation_date": "20141217", "center_classification_date": "20150408", "termination_date": "20150819", "report_date": "20150415", "code_info": "lot number 37-74671, Made on 15 DEC 2014, EXP 24 DEC 2014, CAPS Rx: 37-74671-0-6-R, Disp ID: 37-1124546"}, {"status": "Terminated", "city": "Somerset", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201693"], "brand_name": ["NITROFURANTOIN"], "generic_name": ["NITROFURANTOIN"], "manufacturer_name": ["Lupin Pharmaceuticals,Inc."], "product_ndc": ["43386-450"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NITROFURANTOIN"], "rxcui": ["311989"], "spl_id": ["361dd255-19ba-453f-9b68-ade3185ff390"], "spl_set_id": ["93c37857-38f1-4e2e-acb8-4846840e3e85"], "package_ndc": ["43386-450-11"], "is_original_packager": [true], "nui": ["N0000175494", "M0014892"], "pharm_class_epc": ["Nitrofuran Antibacterial [EPC]"], "pharm_class_cs": ["Nitrofurans [CS]"], "unii": ["927AH8112L"], "upc": ["343386450114"]}, "product_type": "Drugs", "event_id": "80377", "recalling_firm": "LUPIN SOMERSET", "address_1": "400 Campus Dr", "address_2": "", "postal_code": "08873-1145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the US", "recall_number": "D-0927-2018", "product_description": "Nitrofurantoin Oral Suspension USP, 25mg/5mL, 230 mL Bottle, Rx Only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, UPC 343386-450-114, NDC 43386-450-11", "product_quantity": "3456 cartons", "reason_for_recall": "Subpotent Drug and Failed Content Uniformity.", "recall_initiation_date": "20180628", "center_classification_date": "20180718", "termination_date": "20230306", "report_date": "20180718", "code_info": "Lot#: S700065, Exp. 02/2019; 700619, Exp. 08/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Plano", "state": "TX", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "71598", "recalling_firm": "Abrams Royal Pharmacy II, LLC", "address_1": "4909 W Park Blvd Ste 177", "address_2": "N/A", "postal_code": "75093-2311", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including: Texas", "recall_number": "D-1231-2015", "product_description": "CORTISOL-MC, 10mg CAP, packaged in 30 and 90 count bottles, Rx Only, ABRAMS ROYAL pharmacy II, 4909 W Park Blvd, Suite 177, Plano, TX 75093 --- NDC 88888-0043-31", "product_quantity": "30 count: 5 Bottles; 90 count: 2 Bottles", "reason_for_recall": "Failed Content Uniformity Specifications: Failed Uniformity of Dosage Units specifications.", "recall_initiation_date": "20150623", "center_classification_date": "20150708", "termination_date": "20170113", "report_date": "20150715", "code_info": "Lot #: 04012015@45, Expiry: 09/28/2015"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1392-2022", "product_description": "READY IN CASE PAIN RELIEVER PM CAPLET 100 CT SKU 902381   GOOD SENSE PAIN RELIEVER APAP 500MG CAPLET 250CT SKU 902332   READY IN CASE PM PAIN RELIEVER CAPLET 50 CT SKU 913982   GOOD SENSE PAIN RELIEVER APAP ES 500 CT SKU 999029   GOOD SENSE PAIN RELIEVER CAPLET 100 CT SKU 913890 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKUs: 902381; 902332; 913982; 999029; 913890", "more_code_info": ""}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020849"], "brand_name": ["PROSOL"], "generic_name": ["VALINE, LYSINE, HISTIDINE, ISOLEUCINE, LEUCINE, PHENYLALANINE, THREONINE, METHIONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0499"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ALANINE", "ARGININE", "ASPARTIC ACID", "GLUTAMIC ACID", "GLYCINE", "HISTIDINE", "ISOLEUCINE", "LEUCINE", "LYSINE ACETATE", "METHIONINE", "PHENYLALANINE", "PROLINE", "SERINE", "THREONINE", "TRYPTOPHAN", "TYROSINE", "VALINE"], "rxcui": ["801133", "801136"], "spl_id": ["ee240b46-c2a9-42e0-8750-a5a554becea3"], "spl_set_id": ["cc2ace81-5881-43f1-ba94-41b674adc2fc"], "package_ndc": ["0338-0499-06"], "is_original_packager": [true], "nui": ["N0000175780", "M0000922"], "pharm_class_epc": ["Amino Acid [EPC]"], "pharm_class_cs": ["Amino Acids [CS]"], "unii": ["OF5P57N2ZX", "94ZLA3W45F", "30KYC7MIAI", "3KX376GY7L", "TE7660XO1C", "4QD397987E", "04Y7590D77", "GMW67QNF9C", "TTL6G7LIWZ", "AE28F7PNPL", "47E5O17Y3R", "9DLQ4CIU6V", "452VLY9402", "2ZD004190S", "8DUH1N11BX", "42HK56048U", "HG18B9YRS7"]}, "product_type": "Drugs", "event_id": "68963", "recalling_firm": "Baxter Healthcare Corp", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1542-2014", "product_description": "ProSol - sulfite-free (Amino Acid) Injection, 20%, 2000 mL VIAFLEX container bag, Rx only, Baxter Healthcare Corporation, Clinitec Nutrition Division, Deerfield, IL  60015 USA, Product Code 2B6186, NDC 0338-0499-06.", "product_quantity": "6,204 bags", "reason_for_recall": "Presence of Particulate Matter: identification of particulates in a retention sample that have been identified as a mixture of the amino acid leucine and inorganic material (containing iron, silicone and chlorine).", "recall_initiation_date": "20140804", "center_classification_date": "20140818", "termination_date": "20150610", "report_date": "20140827", "code_info": "Lot #: P306225, Exp 08/14", "more_code_info": ""}, {"status": "Terminated", "city": "Missoula", "state": "MT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71275", "recalling_firm": "Montana Compounding Pharmacy", "address_1": "111 N Higgins Ave", "address_2": "N/A", "postal_code": "59802-4437", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MT and ND", "recall_number": "D-1119-2015", "product_description": "Avastin, solution, 1.25 mg/0.05mL, Injectable, Syringe, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT", "product_quantity": "259/0.05 mL Syringes", "reason_for_recall": "Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection", "recall_initiation_date": "20150515", "center_classification_date": "20150609", "termination_date": "20161220", "report_date": "20150617", "code_info": "Lot 04202015:49@1, Expiry date:   5/20/2015;  Lot 04272015:06@6, Expiry date:   6/2/2015;  Lot 04282015:16@13, Expiry date: 6/12/2015;  Lot 05062015:56@3, Expiry date:   5/24/2015;"}, {"status": "Terminated", "city": "Whippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79252", "recalling_firm": "Bayer HealthCare Pharmaceuticals, Inc.", "address_1": "100 Bayer Blvd", "address_2": "N/A", "postal_code": "07981-1544", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Arkansas only", "recall_number": "D-0590-2018", "product_description": "Coppertone Kids Sunscreen Spray (avobenzone 3%, Homosalate 10%, Octisalate 5%, Octocrylene 4%, Oxybenzone 5%) 8.3 oz. bottle, Dist. by: Bayer Healthcare LLC Whippany, NJ 07981, UPC 41100573636.", "product_quantity": "528 units", "reason_for_recall": "Labeling: Label mix-up", "recall_initiation_date": "20180223", "center_classification_date": "20180312", "termination_date": "20200109", "report_date": "20180314", "code_info": "Lot#: 7N04CS, 7N05CS, Exp. 11/2019"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0201-2022", "product_description": "TRI-MIX PAPAVERINE 30/PHENTOLAMINE 0.5/PGE-1 30 INJ  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 06252021:22 BUD: 10/23/2021", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; DOXYCYCLINE HYCLATE, Tablet, 100 mg may be potentially mislabeled as    DESLORATADINE, Tablet, 5 mg, NDC 00085126401, Pedigree: AD30993_5, EXP: 2/28/2014.", "address_2": "", "product_quantity": "50 Tablets", "code_info": "DOXYCYCLINE HYCLATE Tablet, 100 mg has the following code    Pedigree: AD30993_8, EXP: 5/9/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DOXYCYCLINE HYCLATE Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 53489012002", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-611-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Swedesboro", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90403", "recalling_firm": "Wedgewood Village Pharmacy, LLC", "address_1": "405 Heron Dr Ste 200", "address_2": "N/A", "postal_code": "08085-1749", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Products were distributed nationwide in the USA.", "recall_number": "D-1183-2022", "product_description": "Boric Acid 600 mg capsules, 14 capsules per box, Qty: 1, Wedgewood Village Pharmacy LLC, 405 Heron Drive, Ste 200, Swedesboro, NJ 08085", "product_quantity": "1 box", "reason_for_recall": "Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection", "recall_initiation_date": "20220610", "center_classification_date": "20220707", "termination_date": "20230216", "report_date": "20220713", "code_info": "Lot#: 000-03868160, Exp Date: 09/14/22", "more_code_info": ""}, {"status": "Terminated", "city": "Guadalajara", "state": "N/A", "country": "Mexico", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86199", "recalling_firm": "Incredible Products, SA de CV", "address_1": "Calle Castellanos Y Tapia 921", "address_2": "Col. Santa Maria", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "CA and GA", "recall_number": "D-1587-2020", "product_description": "Incredible Products Gelbac T Antibacterial Hand Gel (ethyl alcohol 80%), Kills 99.9% bacteria and germs, a) 4.2 Oz./125 mL bottle, NDC: 71761-000-00, UPC: 7502278002555, Distributed by Pacific Coast Global Inc. Chula Vista, CA 91911, Made in Mexico b) 33.8 Oz./1 L, UPC: 7502278002586, Made in Mexico By Incredible Products S.A. de C.V. alle Castellanos y Tapia 921, Oblatos, 44350 Guadalajara, Jal, MX.", "product_quantity": "N/A", "reason_for_recall": "Chemical Contamination: Product contains methanol as an active ingredient and is sub-potent for ethanol.", "recall_initiation_date": "20200806", "center_classification_date": "20200918", "termination_date": "20240626", "report_date": "20200930", "code_info": "Lot #: 001, Exp. 04/2023"}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "9,006 cases", "code_info": "Product Code: 6962; Lots: 55604, 55619, 56000, 56052 EXP 08/28/2017; 56211, 56282, 56783, EXP 09/26/2017; 57204, 57614, 58027, EXP 11/13/2017; 58549, 58587, EXP 04/03/2018; 59493, EXP 07/16/2018; 60043, 60079, EXP 07/30/2018; 60476, EXPO 08/02/2018; 60490 EXP 09/04/2018; 60790, EXP 09/06/2018; 61405, EXP 09/11/2018; 61456, 61799, EXP 10/16/2018", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "QCare RX Q2 Oral Cleansing & Suctioning System with 0.12% Chlorhexidine Gluconate (CHG) Oral Rinse Corinz. Contains 1 Covered Yankauer and Y-Connector, 2 Untreated Suction Toothbrush packages, 2 Single dose bottles of 0.12% CHG Oral Rinse, 10 Suction Oral Swab packages with Corinz Antiseptic Cleansing and Moisturizing Oral Rinse and 2 Oropharyngeal Suction Catheter packages. Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6962, UPC 6 18029 83076 0", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0354-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0708-2020", "product_description": "BUP 40MG/FENT 3000MCG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12102019@5 Exp. 12/19/2019", "more_code_info": ""}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "98 vials", "code_info": "Lot #: a) Edetate Disodium_150/30 mL: 20130201-E, Exp 5/2/2013; b) Edetate Disodium_150/100 mL: 20130124-B, 4/24/2013; 20130213-B, Exp 5/13/2013; 20130213-C, Exp 5/13/2013; 20130401-B, Exp 7/1/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Edetate Disodium Injection, all strengths and all presentations including a) Edetate Disodium 150/30 mL and b) Edetate Disodium 150/100 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-361-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}]